BeiGene to Present at the Guggenheim Healthcare Talks - 2022 Oncology Conference

Rhea-AI Summary

BeiGene, a global biotechnology company, announces its participation in the Guggenheim Healthcare Talks, 2022 Oncology Conference on February 10, 2022, at 9:00 a.m. ET. Investors can access a live webcast via BeiGene’s [investor website](http://ir.beigene.com) or [HKEX](http://hkexir.beigene.com). An archived replay will be available for 90 days post-event. BeiGene is dedicated to developing innovative medicines to enhance patient treatment outcomes worldwide, with a commitment to improving access for two billion more people by 2030.

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global science-driven biotechnology company, today announced that the Company will participate in the Guggenheim Healthcare Talks, 2022 Oncology Conference on Thursday, February 10, 2022 at 9:00 a.m. ET.

A live webcast can be accessed from the investors section of BeiGene’s website at http://ir.beigene.com or http://hkexir.beigene.com. An archived replay will be available for 90 days following the event.

About BeiGene

BeiGene is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. With a broad portfolio of more than 40 clinical candidates, we are expediting development of our diverse pipeline of novel therapeutics through our own capabilities and collaborations. We are committed to radically improving access to medicines for two billion more people by 2030. BeiGene has a growing global team of approximately 8,000 colleagues across five continents. To learn more about BeiGene, please visit www.beigene.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220208005585/en/

Investor

Kevin Mannix

+1 857-302-5189

ir@beigene.com

Media

Liza Heapes

+1 857-302-5663

media@beigene.com

Source: BeiGene, Ltd.

FAQ

When is BeiGene's presentation at the Guggenheim Healthcare Talks Oncology Conference?

BeiGene will present at the Guggenheim Healthcare Talks Oncology Conference on February 10, 2022, at 9:00 a.m. ET.

How can I access the live webcast of BeiGene's presentation?

The live webcast of BeiGene's presentation can be accessed on their [investor website](http://ir.beigene.com).

Will there be a replay available after BeiGene's presentation?

Yes, an archived replay of BeiGene's presentation will be available for 90 days following the event.

What is BeiGene's mission regarding access to medicines?

BeiGene aims to radically improve access to medicines for two billion more people by 2030.

What is the primary focus of BeiGene as a biotechnology company?

BeiGene focuses on developing innovative and affordable medicines to improve treatment outcomes for patients worldwide.